IP Library Patent Application 17053190
Patent Application
App. No. 17/053,190

Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/053,190
Abstract

The disclosure relates to the field of specialty chemicals and methods for their synthesis. In embodiments, the disclosure provides novel multifunctional fatty acid derivative molecules such as e.g., fatty triols, fatty tetrols, dihydroxy fatty acids, etc. The disclosure further provides derivatives of the disclosed multifunctional molecules which are useful e.g., in the production of personal care products, surfactants, detergents, polymers, paints, coatings, and as emulsifiers, emollients, and thickeners in cosmetics and foods, as industrial solvents and plasticizers, etc. The disclosure further provides biochemical pathways, recombinant microorganisms and methods for the biological production of various multifunctional fatty acid derivatives.

Claims (108)

1 . A multifunctional molecule having a chemical formula according to

wherein

R1=-OH; —O 2 H; —CH 2 ; —CH 2 OH; —CHO; —CH 2 NH 2 ; —CO 2 H; —CO 2 CH 3 ; —CO 2 C 2 H 5 ; —CO 2 C 3 H 7 ; —CO 2 C 2 H 3

R2=-H; —OH; —NH 2

R3=-H; —OH;

R4=-H; —OH;

R5=-CH 3 ; —CH 2 ; —CH 2 OH; —CHO; —CH 2 NH 2 ; —CO 2 H; —CO 2 CH 3 ; —CO 2 C 2 H 5 ; —CO 2 C 3 H 7 ; —CO 2 C 2 H 3 ;

wherein

m=1-10 and n=0-9 and

wherein

if R1 is OH or —O 2 H then 3<m+n≤10; and if R1 is other than OH or —O 2 H, then 2<m+n≤10, and

wherein

the multifunctional molecule has at least three functional groups comprising a heteroatom, and

wherein

at least two of R2, R3 and R4 are OH; or when R5 is other than CH 3 , CH 2 or C 3 H 7 CH 2 H 5 then at least one of R2, R3 and R4 are OH; and

wherein

when R5=CH 3 and R4=H then n=0 or 1; and

wherein

when R2=H, then R4 does not=H; and

wherein

when R3=H, then n+m=p and p=3-10; unless R1=-OH or —O 2 H in which case when R3=-H then n+m=p and p=4-10; and

wherein

when the multifunctional molecule comprises a double bond that is not terminal, the double bond is in a position corresponding to an omega7 (ω-7) position; and

wherein

the multifunctional molecule is not 1,3,12-dodecane triol; is not 3,11-dihydroxy-tetradecanoic acid; is not 3,11-dihydroxy-tetradecanoic acid methyl ester and is not naturally occurring.

2 . The multifunctional fatty acid derivative molecule of claim 1 , wherein the multifunctional fatty acid derivative molecule is a multifunctional alcohol.

3 . The multifunctional fatty acid derivative molecule of claim 2 ,

wherein

R1=CH 2 OH and R2=OH.

4 . The multifunctional fatty acid derivative molecule of claim 3 , wherein the multifunctional fatty acid derivative molecule is a member selected from the group consisting of 1,3,11-dodecane triol, 1,3,-10-dodecane triol, 1,3,9-dodecane triol, 1,3,12-dodecene triol, 1,3,11-dodecene triol, 1,3,10-dodecene triol, 1,3,9-dodecene triol, 1,3,11,12-dodecane tetrol, 1,3,10,12-dodecane tetrol, 1,3,9,12 dodecane tetrol, 1,3,7-decane triol, 1,3,8-decane triol, and 1,3,9-decane triol.

5 . The multifunctional fatty acid derivative molecule of claim 1 , wherein the multifunctional fatty acid derivative molecule is a multifunctional fatty acid ester.

6 . The multifunctional fatty acid derivative molecule of claim 5 , wherein

R1=CO 2 CH 3 and R2=OH.

7 . The multifunctional fatty acid derivative molecule of claim 6 , wherein the multifunctional fatty acid derivative molecule is a member selected from the group consisting of 3,12-dihydroxy dodecanoic acid methyl ester, 3,14-dihydroxy tetradecanoic acid methyl ester, 3,16-dihydroxy hexadecanoic acid methyl ester, 3,12-dihydroxy dodecenoic acid methyl ester, 3,14-dihydroxy tetradecenoic acid methyl ester, 3,16-dihydroxy hexadecenoic acid methyl ester, 3,11-dihydroxy dodecanoic acid methyl ester, 3,10-dihydroxy dodecanoic acid methyl ester, 3,9-dihydroxy dodecanoic acid methyl ester, 3,11-dihydroxy dodecenoic acid methyl ester, 3,10-dihydroxy dodecenoic acid methyl ester, 3,9-dihydroxy dodecenoic acid methyl ester, 3,13-dihydroxy tetradecanoic acid methyl ester, 3,12-dihydroxy tetradecanoic acid methyl ester, 3,13-dihydroxy tetradecenoic acid methyl ester, 3,12-dihydroxy tetradecenoic acid methyl ester, 3,11-dihydroxy tetradecenoic acid methyl ester, 3,15-dihydroxy hexadecanoic acid methyl ester, 3,14-dihydroxy hexadecanoic acid methyl ester, 3,13-dihydroxy hexadecanoic acid methyl ester, 3,15-dihydroxy hexadecenoic acid methyl ester, 3,14-dihydroxy hexadecenoic acid methyl ester, and 3,13-dihydroxy hexadecenoic acid methyl ester.

8 . The multifunctional fatty acid derivative molecule of claim 5 , wherein

R1=CO 2 CH 2 CH 3 and R2=OH.

9 . The multifunctional fatty acid derivative molecule of claim 8 , wherein the multifunctional fatty acid derivative molecule is a member selected from the group consisting of 3,12-dihydroxy dodecanoic acid ethyl ester, 3,14-dihydroxy tetradecanoic acid ethyl ester, 3,16-dihydroxy hexadecanoic acid ethyl ester, 3,12-dihydroxy dodecenoic acid ethyl ester, 3,14-dihydroxy tetradecenoic acid ethyl ester, 3,16-dihydroxy hexadecenoic acid ethyl ester, 3,11-dihydroxy dodecanoic acid ethyl ester, 3,10-dihydroxy dodecanoic acid ethyl ester, 3,9-dihydroxy dodecanoic acid ethyl ester, 3,11-dihydroxy dodecenoic acid ethyl ester, 3,10-dihydroxy dodecenoic acid ethyl ester, 3,9-dihydroxy dodecenoic acid ethyl ester, 3,13-dihydroxy tetradecanoic acid ethyl ester, 3,12-dihydroxy tetradecanoic acid ethyl ester, 3,11-dihydroxy tetradecanoic acid ethyl ester, 3,13-dihydroxy tetradecenoic acid ethyl ester, 3,12-dihydroxy tetradecenoic acid ethyl ester, 3,11-dihydroxy tetradecenoic acid ethyl ester, 3,15-dihydroxy hexadecanoic acid ethyl ester, 3,14-dihydroxy hexadecanoic acid ethyl ester, 3,13-dihydroxy hexadecanoic acid ethyl ester, 3,15-dihydroxy hexadecenoic acid ethyl ester, 3,14-dihydroxy hexadecenoic acid ethyl ester, and 3,13-dihydroxy hexadecenoic acid ethyl ester.

10 . The multifunctional fatty acid derivative molecule of claim 1 , wherein the multifunctional fatty acid derivative molecule is a multifunctional fatty acid.

11 . The multifunctional fatty acid derivative molecule of claim 10 , wherein n≠4.

12 . The multifunctional fatty acid derivative molecule of claim 11 , wherein

R2=H.

13 .- 36 . (canceled)

37 . A method for making a multifunctional fatty acid derivative molecule having a chemical formula according to:

wherein

R1=-OH; —O 2 H; —CH 2 ; —CH 2 OH; —CHO; —CH 2 NH 2 ; —CO 2 H; —CO 2 CH 3 ; —CO 2 C 2 H 5 ; —CO 2 C 3 H 7 ; —CO 2 C 2 H 3

R2=-H; —OH; —NH 2

R3=-H; —OH;

R4=-H; —OH;

R5=-CH 3 ; —CH 2 ; —CH 2 OH; —CHO; —CH 2 NH 2 ; —CO 2 H; —CO 2 CH 3 ; —CO 2 C 2 H 5 ; —CO 2 C 3 H 7 ; —CO 2 C 2 H 3 ;

wherein

m=1-10 and n=0-9 and

wherein

if R1 is OH or —O 2 H then 3<m+n≤10; and if R1 is other than OH or —O 2 H, then 2<m+n≤10, and

wherein

the multifunctional molecule has at least three functional groups comprising a heteroatom, and

wherein

at least two of R2, R3 and R4 are OH; or when R5 is other than CH 3 , CH 2 or C 3 H 7 CH 2 H 5 then at least one of R2, R3 and R4 are OH; and

wherein

when R5=CH 3 and R4=H then n=0 or 1; and

wherein

when R2=H, then R4 does not=H; and

wherein

when R3=H, then n+m=p and p=3-10; unless R1=-OH or —O 2 H in which case when R3=-H then n+m=p and p=4-10; and

wherein

when the multifunctional molecule comprises a double bond that is not terminal, the double bond is in a position corresponding to an omega7 (ω-7) position; and

wherein

the multifunctional molecule is not 1,3,12-dodecane triol; is not 3,11-dihydroxy-tetradecanoic acid; is not 3,11-dihydroxy-tetradecanoic acid methyl ester and is not naturally occurring,

the method comprising:

culturing

a recombinant microbe that comprises a heterologous enzyme pathway capable of producing a bifunctional fatty acid derivative molecule, and at least one heterologous hydroxylating enzyme,

in a culture medium comprising a simple carbon source,

wherein

the heterologous enzyme pathway capable of producing bifunctional fatty acid derivative molecule is selected from:

(i) a heterologous enzyme pathway capable of producing a 3-hydroxy fatty acid;

(ii) a heterologous enzyme pathway capable of producing a 3-hydroxy fatty ester;

(iii) a heterologous enzyme pathway capable of producing a 1,3-fatty diol

(iv) a heterologous enzyme pathway capable of producing a hydroxy fatty acid;

(v) a heterologous enzyme pathway capable of producing a hydroxy fatty ester; and

(vi) a heterologous enzyme pathway capable of producing a fatty diol; and

wherein

the at least one heterologous hydroxylating enzyme is selected from a heterologous hydroxylase enzyme and a heterologous hydratase enzyme or a combination thereof.

38 . The method of claim 37 ,

wherein

the heterologous hydroxylase enzyme is a member selected from the group consisting of omega-hydroxylases (o-hydroxylases), mid-chain hydroxylases, and subterminal hydroxylases.

39 . The method of claim 37 ,

wherein

the heterologous enzyme pathway capable of producing bifunctional fatty acid derivative molecule is the heterologous enzyme pathway capable of producing a 1,3-fatty diol.

40 . The method of claim 39 ,

wherein

the heterologous enzyme pathway capable of producing a 1,3-fatty diol comprises;

(i) a heterologous thioesterase and

(ii) a heterologous carboxylic acid reductase.

41 . The method of claim 40 ,

wherein

the heterologous enzyme pathway capable of producing a 1,3-fatty diol further comprises;

(iii) a heterologous alcohol dehydrogenase.

42 . The method of claim 41 ,

wherein

the heterologous enzyme pathway capable of producing a 1,3-fatty diol further comprises:

(i) a heterologous PhaG thioesterase from Pseudomonas putida,

(ii) a heterologous CarB carboxylic acid reductase from Mycobacterium smegmatis , and

(iii) a heterologous AlrA alcohol dehydrogenase from Acinetobacter baylyi.

43 . The method of claim 40 ,

wherein

the heterologous hydroxylase enzyme is a cyp102A subterminal-hydroxylase from Bacillus licheniformis , and

wherein

the method produces multifunctional molecules selected from the group consisting of 1,3,9 decanetriol, 1,3,8 decanetriol, 1,3,7 decanetriol, 1,3,11 dodecanetriol, 1,3,10 dodecanetriol, 1,3,9 dodecanetriol, (z5)1,3,11 dodecenetriol, (z5)1,3,10 dodecenetriol and (z5)1,3,9 dodecenetriol.

44 .- 60 . (canceled)

Assignments (3)
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2021
From: SCHIRMER, ANDREAS W.; BOND, RISHA LINDIG; PERRY, ERIN FRANCES
To: GENOMATICA, INC.
Reel/Frame 055827/0398 →